(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

CONJUGADOS DE FÁRMACOS DE ANTICORPOS ANTI-PVR HUMANIZADOS

Em AnáliseInvention PatentPCT · IL2023050942

Application data

Number

112025003334

Type

Invention Patent

Filing

09/04/2023

Publication

08/12/2025

PCT

IL2023050942

Progress at the INPI

Examination not yet requested
  1. Filing09/04/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 09/04/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:09/04/2026(10 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/12/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

NECTIN THERAPEUTICS LTD.

IL

Inventors

A. O. (pessoa física)

IL

A. V. (pessoa física)

IL

A. A. (pessoa física)

IL

G. C. (pessoa física)

IL

P. T. (pessoa física)

IL

Technical data

IPC Classification

Priority claims

US

63/403,750 · 09/04/2022

Abstract

CONJUGADOS DE FÁRMACOS DE ANTICORPOS ANTI-PVR HUMANIZADOS. A presente invenção fornece conjugados de anticorpo-fármaco (ADCs) de anti-PVR humanizado (CD155) e o uso dos mesmos no tratamento de doenças, em particular câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

08/12/2025

RPI 2849

Alteração de dados cadastrais

#1.1

03/06/2025

RPI 2826

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.